When pregnant women receive metformin for any reason, there is a reduction in the risk of preeclampsia of about 30%. Metformin reduced weight gain in pregnancy by 17% or three and a half pounds. Excessive weight gain is associated with complications including increased risk of fetal growth anomalies, risk of diabetes during pregnancy, cesarean delivery and pre-eclampsia. It is also associated with long-term (later in life) health risks to the mother including post-partum weight retention, obesity, and increased risk of developing type 2 diabetes and cardiovascular disease. Scientific advances can help us understand why metformin has these benefits.
Preeclampsia, ADMA, and Metformin
Preeclampsia, ADMA, and Metformin
Preeclampsia, ADMA, and Metformin
When pregnant women receive metformin for any reason, there is a reduction in the risk of preeclampsia of about 30%. Metformin reduced weight gain in pregnancy by 17% or three and a half pounds. Excessive weight gain is associated with complications including increased risk of fetal growth anomalies, risk of diabetes during pregnancy, cesarean delivery and pre-eclampsia. It is also associated with long-term (later in life) health risks to the mother including post-partum weight retention, obesity, and increased risk of developing type 2 diabetes and cardiovascular disease. Scientific advances can help us understand why metformin has these benefits.